Literature DB >> 2181514

Chlamydial infections.

J M Graham1, J D Blanco.   

Abstract

Chlamydia causes many human infections and should be treated aggressively. Tetracycline or doxycycline are the drugs of choice, but erythromycin can be used if a drug allergy is present or if tetracyclines are contraindicated. In the pregnant woman, aggressive treatment can improve neonatal outcome. In the United States, each year 155,000 infants are exposed to Chlamydia trachomatis during the birth process, and more than 100,000 will be infected. Of these, 75,000 will get conjunctivitis, and 30,000 will get pneumonia. In pregnancy, erythromycin is the drug of choice, with treatment recommended after initial culture and at term if repeat cultures are positive. If erythromycin is not tolerated, or the patient has an allergy to it, ampicillin or clindamycin may be effective alternatives.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181514

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  4 in total

Review 1.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

2.  Chlamydia trachomatis genital infection.

Authors:  D B Langille; C T Naugler; M R Joffres
Journal:  Can Fam Physician       Date:  1997-09       Impact factor: 3.275

Review 3.  Macrolide antibiotics in paediatric infectious diseases.

Authors:  D R Guay
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

4.  Chlamydia trachomatis infection in rural Nova Scotia.

Authors:  D B Langille; J Shoveller
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.